Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Conditional Myh9 and Myh10 inactivation in adult mouse renal epithelium results in progressive kidney disease
Karla L. Otterpohl, … , Kameswaran Surendran, Indra Chandrasekar
Karla L. Otterpohl, … , Kameswaran Surendran, Indra Chandrasekar
Published October 1, 2020
Citation Information: JCI Insight. 2020;5(21):e138530. https://doi.org/10.1172/jci.insight.138530.
View: Text | PDF
Research Article Cell biology Nephrology

Conditional Myh9 and Myh10 inactivation in adult mouse renal epithelium results in progressive kidney disease

  • Text
  • PDF
Abstract

Actin-associated nonmuscle myosin II (NM2) motor proteins play critical roles in a myriad of cellular functions, including endocytosis and organelle transport pathways. Cell type–specific expression and unique subcellular localization of the NM2 proteins, encoded by the Myh9 and Myh10 genes, in the mouse kidney tubules led us to hypothesize that these proteins have specialized functional roles within the renal epithelium. Inducible conditional knockout (cKO) of Myh9 and Myh10 in the renal tubules of adult mice resulted in progressive kidney disease. Prior to overt renal tubular injury, we observed intracellular accumulation of the glycosylphosphatidylinositol-anchored protein uromodulin (UMOD) and gradual loss of Na+ K+ 2Cl– cotransporter from the apical membrane of the thick ascending limb epithelia. The UMOD accumulation coincided with expansion of endoplasmic reticulum (ER) tubules and activation of ER stress and unfolded protein response pathways in Myh9&10-cKO kidneys. We conclude that NM2 proteins are required for localization and transport of UMOD and loss of function results in accumulation of UMOD and ER stress–mediated progressive renal tubulointerstitial disease. These observations establish cell type–specific role(s) for NM2 proteins in regulation of specialized renal epithelial transport pathways and reveal the possibility that human kidney disease associated with MYH9 mutations could be of renal epithelial origin.

Authors

Karla L. Otterpohl, Brook W. Busselman, Ishara Ratnayake, Ryan G. Hart, Kimberly R. Hart, Claire M. Evans, Carrie L. Phillips, Jordan R. Beach, Phil Ahrenkiel, Bruce A. Molitoris, Kameswaran Surendran, Indra Chandrasekar

×

Figure 4

Inactivation of Myh9&10 results in progressive mislocalization and intracellular accumulation of UMOD in the TAL.

Options: View larger image (or click on image) Download as PowerPoint
Inactivation of Myh9&10 results in progressive mislocalization and i...
(A–L) Representative images from Bouin’s-fixed kidney sections from 6-week-, 9-week-, and 12-week-old mice stained for UMOD and WGA. Images from control kidney sections at 6 weeks (A and B), 9 weeks (E and F), and 12 weeks (I and J) show UMOD (red) localization to the apical membrane. (C and D) Six-week-old cKO kidney cells (D, white arrowhead) containing UMOD-positive intracellular puncta and loss of localization to the apical membrane. (G and H) Kidney sections from 9-week-old cKO mice show accumulation of UMOD in the intracellular and subapical regions (H, white arrowhead), as well as the lumen (G, white arrows). (K and L) Twelve-week-old cKO kidney sections show tubular dilation and excessive accumulation of UMOD in the luminal space. The white boxes mark the enlarged regions represented in the adjacent images. Scale bar: 10 μm. Images are representative of n ≥ 3 kidneys for control and cKO samples. (M–O) Whole-kidney lysate immunoblots detected both the ~100 kDa (mature, black arrowhead) and ~85–87 kDa (immature, black arrow) UMOD proteins. Tubulin (TUB) was used as loading control. (M) Six-week-old cKO kidney lysates show a slight increase in intensity of UMOD compared with controls. (N and O) 9-week-old cKO (N) and 12-week-old cKO (O) kidney lysates show a pronounced increase in UMOD intensity compared with controls. (P) Quantification of the relative density of UMOD bands observed in control and cKO kidney samples. Nine- and 12-week-old cKO samples show a statistically significant increase of UMOD compared with controls (P = 0.000017 and 0.00078, respectively). n = 6 control and 6-cKO samples at each time point. P values were calculated using a multiple t test, 2-tailed. Error bars represent standard deviation. (Q) Immunoblot of PNGase F–treated 12-week-old kidney lysates indicating that UMOD in both control and cKO samples is posttranslationally modified. In treated control samples (lanes 2–4, n = 3), diffuse bands at ~60–70 kDa are present, which correspond to the form of UMOD devoid of all N-linked oligosaccharides. In treated cKO kidney lysates (lanes 6–8, n = 3), PNGase F treatment also deglycosylated UMOD; however, the banding pattern is slightly lower than control samples (~50–60 kDa). One control and 1 cKO sample (lanes 1 and 5, respectively) underwent the same experimental treatment but without PNGase F enzyme and showed 2 diffuse UMOD bands (black arrowhead and arrow). “L” marks the ladder lanes, and molecular weight labels indicate the corresponding bands on the ladders.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts